Catatonia With Mood and Psychotic Features in an Adolescent With Intellectual Disability and Epilepsy
DOI:
https://doi.org/10.25753/BirthGrowthMJ.v35.i3.42453Keywords:
adolescent, catatonia, epilepsy, intellectual disability, mood disorders, psychotic disordersAbstract
We present the case of a 15-year-old girl with moderate intellectual disability and epilepsy secondary to mesial temporal sclerosis who developed catatonia during a severe mood episode with psychotic features.
Her clinical course was marked by sudden behavioural regression, mutism, motor rigidity and insomnia, requiring inpatient psychiatric admission. After partial remission, she was discharged but relapsed two weeks later with worsening catatonia, urinary incontinence, gait disturbance and behavioural disorganisation, prompting further investigation and readmission.
The overlap between neurological, developmental and psychiatric symptoms posed diagnostic challenges, especially in distinguishing catatonia from seizure-related or medication-induced phenomena. Treatment included benzodiazepines, antipsychotic adjustments and mood stabilisers, with close monitoring of neurological comorbidities. Clinical improvement followed the introduction of lorazepam and replacement of risperidone with aripiprazole.
This case illustrates the complexity of catatonic psychosis in adolescents with neurodevelopmental and epileptic comorbidities, highlighting the importance of early recognition, tailored pharmacological intervention and multidisciplinary collaboration.
Downloads
References
Wilcox JA, Reid Duffy P. The syndrome of catatonia. Behav Sci (Basel) 2015; 5(4): 576–88. https://doi.org/10.3390/bs5040576.
Sienaert P, Dhossche DM, Vancampfort D, De Hert M, Gazdag G. A clinical review of the treatment of catatonia. Front Psychiatry 2014; 5: 181. https://doi.org/10.3389/fpsyt.2014.00181.
Consoli A, Raffin M, Laurent C, et al. Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophr Res 2012; 137(1–3): 151–58. https://doi.org/10.1016/j.schres.2012.02.012.
Kanner AM. Psychiatric comorbidities in epilepsy: should they be considered in the classification of epileptic disorders? Epilepsy Behav 2016; 64: 306–8. https://doi.org/10.1016/j.yebeh.2016.06.040.
Emerson E. Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability. J Intellect Disabil Res 2003; 47(Pt 1): 51–8. https://doi.org/10.1046/j.1365-2788.2003.00464.x.
Moore S, Amatya DN, Chu MM, Besterman AD. Catatonia in autism and other neurodevelopmental disabilities: a state-of-the-art review. NPJ Ment Health Res 2022;1: 12. https://doi.org/10.1038/s44184-022-00012-9.
Helmstaedter C, Witt JA. Epilepsy and cognition – a bidirectional relationship? Seizure 2017; 49: 83–9. https://doi.org/10.1016/j.seizure.2017.02.017.
Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 1996; 93(2): 129–36. https://doi.org/10.1111/j.1600-0447.1996.tb09814.x.
Kanner AM, Rivas-Grajales AM. Psychosis of epilepsy: a multifaceted neuropsychiatric disorder. CNS Spectr 2016; 21(3): 247–57. https://doi.org/10.1017/S1092852916000250.
Brugger F, Bhatia KP, Besag FM. Valproate-associated parkinsonism: a critical review of the literature. CNS Drugs 2016; 30(6): 527–40. https://doi.org/10.1007/s40263-016-0341-8.
Zhu LN, Chen D, Tan G, et al. The tolerability and safety profile of eslicarbazepine acetate in neurological disorders. J Neurol Sci 2020; 413: 116772. https://doi.org/10.1016/j.jns.2020.116772.
Pennell PB. Hormonal aspects of epilepsy. Neurol Clin 2009; 27(4): 941–65. https://doi.org/10.1016/j.ncl.2009.08.005.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Tiago Soares, Débora Stolnik, Ana Rita Rodrigues, João Paulo Guerra

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in the Birth and Growth Medical Journal are Open Access and meet the requirements of funding agencies and academic institutions. Third-party use of published content is permitted under the terms of the Creative Commons Attribution-NonCommercial (CC BY-NC) license. It is the responsibility of authors to obtain permission for reproducing figures, tables, or other materials from previously published works.
Authors must submit a Conflict of Interest statement and an Authorship Form together with their manuscript. A confirmation email will be sent to the corresponding author upon receipt of the submission. Authors are also permitted to deposit their articles in institutional or personal repositories, provided that the original publication in the Birth and Growth Medical Journal is clearly indicated and the terms of the Creative Commons license are respected.